Month: June 2014

Recon takes an analytical look behind select developments in healthcare

Apple HealthKit, provider partnerships and walled gardens: three observations

Tory Wolff June 9, 2014

A number of observers have noted that the Apple’s partnership with Epic on HealthKit could reinforce the role of “closed IT system” strategies in general and Epic’s leading position among EMR vendors in particular. Others have noted that prominent PHR failures (Google, Revolution Health) should add some sobriety to the hype around HealthKit. While I don’t disagree with these concerns, I have three other thoughts on the announcement that Apple has built a framework for collecting and presenting health data from a wide variety of consumer devices and apps. Providers

Can drug companies make drugs, AND money?

Nikhil Bhojwani June 3, 2014

In this morning’s New York Times (June 3,2014), Andrew Ross Sorkin asks,“DO drug companies make drugs, OR money”? That’s a fair question in the context of what I’ll call a “fee-for-product” reimbursement regime. Another way to look at this question is, “CAN drug companies make drugs, AND money”? Value has not been an easy sell As the U.S. healthcare services system moves from fee-for-service to a value-based system, the biotech and pharmaceutical (biopharma) industry should have an opportunity to capture more of the value it creates. But with drug costs only ~10%

Recon Strategy Opens West Coast Office

wpadmin June 1, 2014

Recon Strategy’s West Coast operation is to be headed by co-founder and Managing Partner, Tory Wolff. The new office is based out of Seattle.

Month: June 2014

Recon takes an analytical look behind select developments in healthcare

Apple HealthKit, provider partnerships and walled gardens: three observations

Can drug companies make drugs, AND money?

Recon Strategy Opens West Coast Office

SUBSCRIBE

Categories

Authors

Archives